How did professional nursing organizations (AAN, ANA) respond to any regulatory changes affecting nurses under Trump?
This fact-check may be outdated. Consider refreshing it to get the most current information.
Executive summary
Professional nursing organizations, led publicly by the American Nurses Association (ANA) and joined by academe groups like the American Association of Colleges of Nursing (AACN), mounted a mix of defensive and proactive responses to Trump-era regulatory changes—issuing public statements and petitions, engaging in regulatory comment processes, lobbying Congress and federal agencies, and selectively cooperating with administration proposals that expanded advanced practice scope—while also facing internal membership backlash over perceived political caution [1] [2] [3] [4] [5] [6].
1. Public pushback: statements, petitions and alarms about loan and budget changes
When the Trump administration’s regulatory moves reclassified or excluded nursing from the Department of Education’s “professional degree” category—an administrative change that groups warned would limit graduate loan access—ANA and allied organizations publicly denounced the move, warned it would “severely restrict access to critical funding for graduate nursing education,” launched petitions to reverse the change, and urged DoED and Congress to act to protect nursing education funding [2] [1] [7] [8]. The ANA’s framing emphasized threats to workforce pipeline and patient care, and the organization called for the Department to explicitly include post‑baccalaureate nursing programs in the regulatory definition of professional degrees [2] [1].
2. Regulatory engagement and formal comment: working the rulemaking process
Beyond public statements, ANA systematically engaged the administrative rulemaking process—submitting comments to Requests for Information, tracking CMS payment rules, and signaling readiness to use regulatory comment periods and congressional outreach to shape outcomes—an approach the organization detailed in its Capitol Beat commentary and policy communications [9] [3]. That mix of technical advocacy and stakeholder mobilization reflects a classic association strategy: contesting adverse administrative definitions while attempting to influence implementation details like telehealth flexibility, safe staffing metrics, and nurse‑led care planning [9].
3. Selective cooperation: support for scope expansion and deregulation that benefits APRNs
At the same time, nursing organizations did not oppose every Trump administration initiative; AACN and ANA materials show they welcomed regulatory changes that removed supervision barriers and expanded APRN practice under Medicare, framing such reforms as long‑sought steps to improve access and allow nurses to practice at the top of their license [4] [5] [10]. These cooperative stances were leveraged to press for parallel protections—evidence‑based quality measures and workforce supports—to ensure scope changes would not erode care quality [9] [10].
4. Defensive politics: challenging proposed cuts to nursing research and programs
When leaked HHS budget proposals and other Trump‑era fiscal moves suggested cuts to Title VIII nursing programs and nursing research, ANA publicly condemned the proposals and urged the administration and Congress to reconsider, emphasizing the cost‑effective benefits of existing workforce and education programs [11]. That defensive posture combined public rebuke with targeted legislative outreach—a dual track of media statements and direct engagement with members of Congress and federal staff [3] [11].
5. Internal tensions and organizational constraints shaping responses
ANA’s responses were constrained—and contested—internally: some members criticized the association for not taking more overt political stands (for example, refusing to endorse candidates), while the leadership argued for a strategy focused on regulatory advocacy, stakeholder engagement, and legal analysis of executive orders rather than partisan declarations [6] [3]. This tension illustrates an unstated agenda common to professional associations: balance member diversity and tax‑exempt advocacy rules against the urgency of public health advocacy, which can lead to perceived timidity even as the organization pursues technical, behind‑the‑scenes leverage [6] [3].
Conclusion: advocacy in multiple modes, calibrated by organizational limits
Overall, the ANA and allied nursing organizations responded to Trump‑era regulatory changes by mobilizing public campaigns (petitions and media statements), participating in the formal rulemaking and congressional processes, pushing back strongly against funding cuts, and selectively cooperating when deregulatory moves expanded nursing scope—while navigating internal member divisions and the constraints of institutional neutrality that sometimes limited more overt political confrontation [1] [2] [3] [4] [11] [6] [5]. Reporting limitations prevent a comprehensive cataloging of every meeting, legal action, or behind‑the‑scenes negotiation these groups pursued, but the public record shows a multipronged, pragmatic strategy: defend funding and education pathways, seize scope‑expanding regulatory opportunities, and engage formal processes to shape implementation [9] [2] [5].